- AU$105.46m
- AU$40.81m
- $1.62m
Brief: EBR Systems Submits TGA ARTG Application For Wise® System
Australia's EBR Systems hits record low on weak third-quarter revenue outlook
Brief: EBR Systems Forecasts Q3 2026 Revenue Of US$2.4 MLN To US$2.5 MLN
Brief: EBR Systems Announces Its Plan To Submit A Changes For Supplements To FDA In Q4 2026
Australia's EBR Systems heads for worst week in nearly two months after US FDA risk assessment
Australia's EBR Systems falls after US FDA's risk assessment
Brief: EBR Systems Provides Update On FDA Review Of Cybersecurity Incident
Brief: EBR Systems Responds To Media Speculation On Serious Patient Complications With Wise System
Brief: EBR Systems Seeks Trading Halt
Brief: EBR Systems Secures Purchasing Agreement With Christus Health
Australia's EBR Systems jumps on securing U.S. purchase agreement
Brief: EBR Systems Purchasing Agreement Secured With HCA Healthcare
Brief: Ebr Systems Inc Says TGA Grants Priority Review Determination For Wise System
Brief: EBR Systems Experiences Data Security Breach
Australia's EBR Systems flags possible unauthorised access to patient health data (updated)
Australia's EBR Systems flags possible unauthorised access to patient health data
Brief: EBR Systems Expects To Report Revenue In Range Of US$2.25M To US$2.36M For Q1
Brief: Ebr Systems Says To Change Chess Depositary Interests To Share Conversion Ratio To 10-To-1
Australia's EBR Systems rises on first patient enrolment in CRT study